Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis: A prospective, controlled pilot study
- 28 February 1997
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (2) , 325-330
- https://doi.org/10.1016/s0168-8278(97)80048-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Bone disease in primary biliary cirrhosis: Does ursodeoxycholic acid make a difference?Hepatology, 1995
- Primary biliary cirrhosis and bone diseaseHepatology, 1995
- A randomized placebo-controlled trial with prednisone/azathioprine in addition to ursodeoxycholic acid in primary biliary cirrhosisJournal of Hepatology, 1994
- Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosisBone, 1993
- Journal of Bone and Mineral ResearchJournal of Bone and Mineral Research, 1993
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992
- Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosisHepatology, 1991
- Prevalence and Prediction of Osteopenia in Chronic Liver DiseaseHepatology, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone lossHepatology, 1989